FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 139 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,322,000 | +262.2% | 77,726 | +0.1% | 0.01% | +100.0% |
| Q3 2020 | $365,000 | +212.0% | 77,624 | +305.1% | 0.01% | +150.0% |
| Q2 2020 | $117,000 | +80.0% | 19,164 | -32.9% | 0.00% | 0.0% |
| Q1 2020 | $65,000 | -39.8% | 28,576 | +21.6% | 0.00% | +100.0% |
| Q4 2019 | $108,000 | -86.6% | 23,500 | -88.7% | 0.00% | -85.7% |
| Q3 2019 | $805,000 | +290.8% | 207,823 | +506.9% | 0.01% | +250.0% |
| Q2 2019 | $206,000 | -8.4% | 34,242 | +103.9% | 0.00% | 0.0% |
| Q1 2019 | $225,000 | -67.5% | 16,795 | -77.4% | 0.00% | -75.0% |
| Q4 2018 | $692,000 | -49.6% | 74,440 | -24.5% | 0.01% | -50.0% |
| Q3 2018 | $1,372,000 | +120.9% | 98,555 | +150.8% | 0.02% | +100.0% |
| Q2 2018 | $621,000 | +17.4% | 39,300 | +62.9% | 0.01% | -11.1% |
| Q4 2017 | $529,000 | -13.4% | 24,118 | +42.7% | 0.01% | -47.1% |
| Q1 2017 | $611,000 | -14.7% | 16,896 | +18.3% | 0.02% | -41.4% |
| Q4 2016 | $716,000 | +186.4% | 14,282 | +131.9% | 0.03% | +52.6% |
| Q1 2016 | $250,000 | -8.8% | 6,159 | -6.7% | 0.02% | -36.7% |
| Q4 2015 | $274,000 | – | 6,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |